Clinical Trial

A Randomized Controlled Trial to Address a Multimodal Intervention in the Elderly

Study acronym: CAMINN
Completed
View on ClinicalTrials.gov →
Summary
The study is a quantitative randomized control trial (RCT) with a longitudinal pre-test, mid-test and post-test within and between subject design. It was conducted between July 2023 and December 2024. This study has been developed under a multicenter basis, since the intervention has involved institutionalized participants in two different nursing homes/care facilities as well as participants in community-dwelling settings. Participants were randomly allocated to two groups (experimental and control). Randomization was performed by means of a computer-generated random number schedule. The trial began with 187 participants. The objective of the intervention was to determine if after the application of a multimodal intervention for 18 months, the subjects would obtain significant improvements in the scores of different clinically validated tests
Trial Details
NCT Number NCT07362381
Lead Sponsor Universidad de Zaragoza
Collaborators: Ingesan-OHLA
Conditions People 60 Years of Age or Over 55 Years of Age With a Diagnosed Pathology and Preferably With a Recognized Physical and/or Cognitive Dependency
Enrollment 187 participants
Start Date 2023-07-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-23